A phase IB study to evaluate the safety, pharmacokinetics, and effects of (+)-calanolide A on surrogate markers in HIV-positive patients with no previous antiretroviral therapy.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2009
At a glance
- Drugs Calanolide A (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 27 Oct 2005 New trial record.